Replies to post #570989 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

And 100% there are better companies that inform their shareholders and meet their timelines. Hopefully, UK submission is near and you can get out with some profit and still keep your sanity!

Hope that too thanks. :-)

Complete response letters (CRL) can happen for various reasons including manufacturing.

Ps when I said, "NWBO could have met those timelines had they stuck with CRL for DCVAX production." I meant Charles River Labs as the CDMO with NWBO had years of affiliation and paid millions (for no reason looking back now) to reserve production capacity.

[Smitty5150]

Its my opinion, that eventually, and probably very soon, Advent and NW Bio will merge. This will solve a few problems they are currently experiencing. Executives at gene therapy biotechs BioMarin Pharmaceutical, MeiraGTx and Audentes Therapeutics have all gone this route. All three have invested in their own internal manufacturing.

I am no expert in the "short squeeze" theory, but someone I know is. While its not the only reason, this would be one of the incentives from CEO Linda Powers to consider a move such as this, and I 100% believe its on the table if not being finalized. All shares would need to be accounted. Imagine.